U-PMCB

Q:PMCB - PHARMACYTE BIOTECH INC - https://www.pharmacytebiotech.com

16:05:27 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PMCB - Q	4.8	0.7419	·	0.78	0.5	0.761	-0.009	-1.2	46.9	31	106	0.788 0.788 0.7419	1.51 0.63	15:46:18	Nov 25	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 106

More trades...

Time ET	Ex	Price	Change	Volume
15:46:18	Q	0.76	-0.01	49
15:45:05	Q	0.761	-0.009	2
15:39:48	Q	0.78	0.01	80
15:39:33	Q	0.78	0.01	30
15:31:23	Q	0.78	0.01	5
15:31:18	Q	0.745	-0.025	5
15:26:57	Q	0.761	-0.009	100
15:06:22	Q	0.761	-0.009	8
15:00:45	Q	0.751	-0.019	100
14:59:52	Q	0.7425	-0.0275	5

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-11-25 09:15	U:PMCB	News Release200	PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
2025-09-02 09:20	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
2025-08-20 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
2025-08-18 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Date ET

Symbol

Type

Headline

2025-11-25 09:15

U:PMCB

News Release

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

2025-09-02 09:20

U:PMCB

News Release

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications